| answer text |
<p>The United Kingdom has a comprehensive surveillance system in place combining laboratory
diagnoses data, risk/behaviour data, outcome data, statistical modelling and service
evaluation to monitor the cascade of care, detect outbreaks, and generate burden estimates.
The UK already has a comprehensive national programme of screening of blood donors
and blood transfusions for blood-borne viruses, including hepatitis C, to ensure safe
supplies – 100% of blood donors are screened with quality assured methods. There is
national guidance and legislation around infection control in healthcare settings
including a policy for healthcare workers to prevent nosocomial transmission of blood-borne
viruses. Prevention efforts in minimising harm in people who inject drugs is focused
on access to opiate substitution therapies and needle syringe exchange programmes,
and disinfection tablets in prisons.</p><p>Public Health England has published hepatitis
C metrics for the report “Hepatitis C in the UK 2016 report - Working towards its
elimination as a major public health threat”. The report is available at the link
below:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/541317/Hepatitis_C_in_the_UK_2016_report.pdf"
target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/541317/Hepatitis_C_in_the_UK_2016_report.pdf</a></p>
|
|
